Davol XenMatrix Surgical Graft Recall Issued For High Levels of Endotoxins

  • Written by: Staff Writers

Federal regulators say that contamination levels in some XenMatrix Surgical Grafts could lead to serious and potentially fatal injuries if used on a patient. 

The FDA has classified a XenMatrix Surgical Graft recall issued in January as a Class 1 medical device recall, meaning that the agency believes there is a reasonable probability of death or serious injury for any patient implanted with a contaminated grafts.

The XenMatrix recall was first announced in a letter to customers sent on January 6 by Davol, a subsidiary of C.R. Bard, after samples of the hernia and abdominal surgical graft were found to contain endotoxins that exceed the FDA’s acceptable levels. However, the company indicates that there have been no consumer complaints regarding problems with the XenMatrix.

Davol acquired the XenMatrix in September 2009 from Brennan Medical. It is a collagen matrix patch used to treat hernias in the abdominal wall when the connective tissue has ruptured.

Endotoxins are usually gram-negative bacteria which can cause toxicity in the human body. Examples include bacterial meningitis, and meningococcal disease; which causes sepsis.

The endotoxins have been detected in several lots. The affected XenMatrix Surgical Grafts have lot numbers beginning with the following four letters: HUTF, HUTI, HUTJ, HUTK, HUTL, HUUA, HUUB, HUUC, HUUD, HUUE, HUUF, HUUG, HUUH, and HUUJ. The grafts were distributed between July 1, 2010 and October 31, 2010.

The XenMatrix is not the only surgical product that C.R. Bard and Davol have had problems with in recent years. The companies currently face about 3,000 lawsuits over their Kugel hernia patch products, which allegedly contain design defectives that caused plaintiffs to suffer severe internal injuries. A Kugel hernia mesh recall has been issued for several different models of the patch.

C.R. Bard also faces a growing number of Bard Avaulta lawsuits, involving their vaginal surgical mesh that is used to treat pelvic organ prolapse in women. Complaints allege that the Bard Avaulta system was negligently designed and that the company failed to warn patients of possible complications that can result in severe pain and disfigurement. In October, the federal Bard Avaulta litigation was consolidated for pretrial proceedings in the U.S. District Court for the Southern District of West Virginia as part of a multidistrict litigation (MDL).

Tags: , , , , , , , ,


  1. hilda Reply

    I had the xenmatrix mesh implant in 2013. for the past 2 years I have bee in so much pain. im been in and out of hospitals looking for some kind of relief. but they cant figure it out. I had my scar adhesions removed this year in 2015. now im feeling bumps again in my navel area and pain where it shoots down my legs. walking is a mess.. I have pains in my lower and upper abdomen and diarrhea. living in fear for the worst……………….hilda

  2. Kenneth Reply

    I had a TiMesh (titanium/polypropylene mesh) from Biomet Inc. completely fragment. I have been searching for 1 1/2 years to find any liability information and have run into deaqd ends…

  3. Tonya Reply

    Had a XenMatrix Dec 2011 had to have it removed in Jan 2012. Lots of complications.

  • Share Your Comments

  • Have Your Comments Reviewed by a Lawyer

    Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.
  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.
Contact A Lawyer

Contact A Lawyer

Have A Potential Case Reviewed By An Attorney

  • This field is for validation purposes and should be left unchanged.